- Lobbying
- Lobbying by Boehringer Ingelheim Pharmacuticals, Inc.
Lobbying Relationship
Bills mentioned
S.999: Stroke Treatment and Ongoing Prevention Act of 2008
Sponsor: Thad Cochran (R-Miss.)
H.R.477: Stroke Treatment and Ongoing Prevention Act
Sponsor: Lois Capps (D-Calif.)
S.2029: Physician Payments Sunshine Act of 2007
Sponsor: Charles E. Grassley (R-Iowa)
H.R.5605: Physician Payments Sunshine Act of 2008
Sponsor: Peter A. DeFazio (D-Ore.)
H.R.3610: Food and Drug Import Safety Act of 2007
Sponsor: John D. Dingell (D-Mich.)
H.R.5839: Safeguarding America's Pharmaceuticals Act of 2008
Sponsor: Steve Buyer (R-Ind.)
H.R.4677: To suspend temporarily the duty on Cyclopropylaminonicotinic acid.
Sponsor: Christopher S. Murphy (D-Conn.)
S.3297: Advancing America's Priorities Act
Sponsor: Harry Reid (D-Nev.)
H.R.6432: To amend the Federal Food, Drug, and Cosmetic Act to revise and extend...
Sponsor: Frank Pallone (D-N.J.)
S.2408: Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
Sponsor: John Kerry (D-Mass.)
H.R.4296: Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
Sponsor: Allyson Y. Schwartz (D-Pa.)
H.R.6331: Medicare Improvements for Patients and Providers Act of 2008
Sponsor: Charles B. Rangel (D-N.Y.)
S.1951: Fair Medicaid Drug Payment Act of 2007
Sponsor: Max Baucus (D-Mont.)
H.R.3700: Fair Medicaid Drug Payment Act of 2007
Sponsor: Frank Pallone (D-N.J.)
S.3101: Medicare Improvements for Patients and Providers Act of 2008
Sponsor: Max Baucus (D-Mont.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Henry W Menn, III Mr. | n/a |
Michael Lewan Mr. | n/a |
Doyce Boesch Mr. | n/a |
Ruth Smith Ms. | n/a |
Jim Bonham Mr. | n/a |
Anne Fabry Ms. | n/a |
Marlene English Ms. | n/a |
Henry W Menn III | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate